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Trends
Aging animals show global, often non-
speciﬁc changes in gene expression.
Epigenetic marks such as the acetyla-
tion of histones change substantially
when animals age. These changes
can already be observed when animals
reach midlife.
Changes in key metabolites during
early aging result in changes in post-
translational modiﬁcations of metabolicReview
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Loss of cellular homeostasis during aging results in altered tissue functions and
leads to a general decline in ﬁtness and, ultimately, death. As animals age, the
control of gene expression, which is orchestrated by multiple epigenetic factors,
degenerates. In parallel, metabolic activity and mitochondrial protein acetyla-
tion levels also change. These two hallmarks of aging are effectively linked
through the accumulating evidence that histone acetylation patterns are sus-
ceptible to alterations in key metabolites such as acetyl-CoA and NAD+, allow-
ing chromatin to function as a sensor of cellular metabolism. In this review we
discuss experimental data supporting these connections and provide a context
for the possible medical and physiological relevance.enzymes. This potentially leads to a
transient increase in metabolic activity
when animals reach midlife.
Age-dependent changes of histone
acetylation are coupled to altered
metabolic activity in aging animals,
which could potentially inﬂuence global
gene expression.
Mutations in genes that link metabolism
and chromatin, such as lysine acetyl
transferases (KATs), lysine deacety-
lases (KDACs) (sirtuins), and ATP citrate
lyase (ACLY/ATPCL), have been shown
to inﬂuence lifespan and the develop-
ment of age-associated diseases.
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Several of the classical hallmarks of aging [1] correlate with epigenetic alterations that regulate
transcription. Aged animals frequently show changes in gene expression [2], increased genomic
instability, an erosion of telomeres, and increased cellular senescence [3]. These distinct hall-
marks functionally interact with each other and affect other hallmarks such as mitochondrial
dysfunction or deregulated nutrient sensing. A current challenge is to identify the functional and
temporal hierarchy among these hallmarks to shed light on the connectivity of the underlying
molecular processes. Such insight might allow us to identify intervention strategies that target
the early stages of the aging-associated decline. Despite the frequently observed correlation
between animal aging and epigenetic changes [4], the molecular mechanisms that cause these
alterations are far from being understood. In this review we focus on recent data describing how
acetyl-CoA metabolism and histone acetylation could lead to an age-associated disruption of
the transcriptome thereby affecting animal lifespan. This intricate connection between metabo-
lism and chromatin also inﬂuences aging-associated tissue degeneration and dysfunction.
However, due to space constraints we mainly discuss its impact on lifespan.
Gene Expression Is Altered during Aging
Multiple studies have reported that alterations in the transcriptional output affect apparently
unrelated genes [2,5] (Figure 1). Consistent with a stochastic loss of transcriptional control
during aging, single-cell analysis of heart muscle tissue from young and old mice showed an
increased cell-to-cell variation in transcription [6]. In yeast such error-prone transcription has
been shown to result in proteotoxic stress and a shortened cellular lifespan [7].
Such a general change in transcription may be indicative of a general loss in chromatin structure.
Aging ﬂies show a loss of transcriptional repression of transposable elements in the adult brain,
indicating a deterioration of heterochromatin [8]. Such a loss of repression of otherwise silenced700 Trends in Biochemical Sciences, August 2016, Vol. 41, No. 8 http://dx.doi.org/10.1016/j.tibs.2016.05.008
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Figure 1. Chromatin Structure and Function as a Biological Clock during Aging. The transformation from young to
old animal is accompanied by diverse changes in chromatin structure. Young animals display tight regulation of gene
expression, maintenance of heterochromatic regions, and suppression of transposon elements. During midlife, a sub-
stantial shift in gene expression proﬁles is ﬁrst observed. Old animals display a larger disruption of the transcriptome,
reduced ability to suppress transposons, loss of heterochromatin regions, and the appearance of senescence-associated
heterochromatin foci (SAHFs).repetitive DNA chromatin has also been observed in liver and muscle tissue of old mammals [9].
A role of repressive chromatin in counteracting organismal aging is also supported by the recent
ﬁnding that mutations impairing heterochromatin stability result in a premature aging phenotype
[10].
The lack of repression as indicated by increased transposon activity is also observed in
senescent mammalian cells [11], which have been proposed to contribute to organismal aging.
This correlation between aging and cellular senescence has been suggested to occur due to
impaired cellular homeostasis mediated either by a disruption of the stem cell niche or by the
induction of an inﬂammatory response through the secretion of proinﬂammatory growth factors
and cytokines [12]. Interestingly, senescent cells form so-called senescence-associated het-
erochromatin foci (SAHFs), which have been suggested to be caused by increased levels of
repressive heterochromatin in these cells [13]. This is in apparent contradiction to the increased
transcription of transposable elements that is usually repressed by heterochromatin [11]. A
hypothesis that could possibly explain this contradiction is that the loss of repression at repetitive
DNA is induced by a redistribution of known heterochromatic factors from classic heterochro-
matin to SAHFs in senescent cells (Figure 1). An accumulation of senescent cells in an organism
is very likely to have a negative impact on lifespan as it was recently shown that clearance of
senescent cells in mice is linked with a substantial increase in lifespan [14].Trends in Biochemical Sciences, August 2016, Vol. 41, No. 8 701
In addition to showing a general impairment of transcriptional regulation, aging animals also
show increases in aberrant RNA splicing [15]. Considering that chromatin structure has been
shown to be involved in the regulation of alternative splicing [16,17], chromatin structure
changes during aging may thus contribute to alternative splicing.
In addition to a loss in transcriptional precision that affects genes in a random manner, in some
cases speciﬁc pathways also appear altered in aged animals [2,5]. A mutation in the histone
demethylase UTX1, for example, delays aging in worms by targeting the insulin/IGF-1 signaling
pathway [18]. Moreover, genes associated with inﬂammation and stress are often upregulated in
old animals, while genes encoding mitochondrial and lysosome functions are reduced [2,19].
These observations underpin the complexity of the underlying changes in chromatin-transcrip-
tional pathways during aging.
Reduction of Histone Levels and Speciﬁc Histone Modiﬁcations Contribute
to Reduced Transcriptional Precision during Aging
The histone proteins both package the DNA and participate in gene expression regulation. It has
been previously shown that old human cells have reduced histone synthesis [20,21] and that
elevated histone expression results in lifespan extension in Saccharomyces cerevisiae [22]. In
addition, speciﬁc histone variants such as macroH2A or H3.3 and its proteolytically processed
form have been suggested to contribute to senescence [23,24].
An important aspect of histone biology is their potential to acquire a rich landscape of various
post-translational modiﬁcations that affect their interaction with DNA or chromatin-associ-
ated proteins. These modiﬁcations have been shown to play a major role in the establish-
ment and maintenance of speciﬁc gene expression proﬁles [25]. Besides being involved in
transcriptional activation or repression, histone modiﬁcations affect transcriptional ﬁdelity
through the regulation of alternative splicing events [17] or the inhibition of initiation from
cryptic promoters [26]. It is therefore conceivable that the observed loss in transcriptional
precision is causally related to a change in histone modiﬁcations. A point mutant in lysine 36
of histone H3, a residue that is otherwise methylated to prevent transcription from cryptic
promoters within coding regions, results in lifespan shortening in yeast [27]. Moreover, while
reducing levels of H3K36 demethylases also increases lifespan in yeast and Caenorhabditis
elegans, mutations in the H3K4 methyltransferases reduce lifespan [27,28]. Importantly,
while these studies show that the loss of transcription ﬁdelity during aging can be counter-
acted by modulating the activities of speciﬁc histone-modifying enzymes in yeast and
worms, whether similar intervention strategies would work in mammals and in humans
needs to be further tested [29]. In the following, we discuss the connection between histone
acetylation, cellular metabolism, and aging in detail.
Histone Acetylation Is a Major Regulator of Transcription
Histone acetylation promotes transcription by weakening electrostatic interactions between
DNA and histones and between adjacent nucleosomes within a nucleosomal ﬁber [30] In
addition, acetylated histones form recognition sites for bromodomain-containing proteins, which
are often found in transcriptional coregulators [31]. Acetylated histones are enriched over active
genes and recruitment of lysine acetyltransferases (KATs), also referred to as histone acetyl-
transferases (HATs), increases transcription in vitro and in vivo [32,33].
According to the prevailing view, histone acetylation functions largely through the cumulative
charge effects of many individual acetylation events as, at least in vitro, bromodomains discrimi-
nate rather weakly between individual acetylation sites [31,34–36]. However, recent studies
challenge this view and indicate that some of the described redundancies are due to limited
speciﬁcity of acetylation-directed antibodies (Box 1). For example, most acetylation antibodies702 Trends in Biochemical Sciences, August 2016, Vol. 41, No. 8
Box 1. Methods for Studying Histone Modiﬁcations: Challenges and Recent Technical Progress
Histone modiﬁcations are commonly monitored with antibodies. The development of antibodies with afﬁnity towards
speciﬁc histone modiﬁcations at speciﬁc amino acids (‘sites’) in the early 1990s revolutionized research on chromatin
biology [110,111]. However, the generation of modiﬁcation-speciﬁc antibodies is difﬁcult because modiﬁcations like
acetylation and methylation add only minor chemical alterations to the epitope recognized by the antibody.
Recent evidence raises considerable caution regarding the speciﬁcity of these antibodies and hence the interpretation of
the data acquired using these reagents [37,112]. Antibody binding is often modulated by adjacent modiﬁcations,
resulting in crossreactivities among similar peptide sequences (e.g., H3K9 and H3K27 are embedded in the same ARKS
motif), and lysine methylation-directed antibodies frequently crossreact towards lower methylation states. Moreover,
polyclonal antibodies can have substantial lot-to-lot variations, which can be reduced with recombinant antibodies [113].
In summary, strict antibody-validation procedures must be applied to assess the speciﬁcity of these reagents and allow
biological interpretation.
Mass spectrometry offers an alternative method to study histone modiﬁcations. Mass spectrometry enables identiﬁcation
of new modiﬁcation types and sites, the reliable quantiﬁcation of extensive sets of modiﬁcations in one experiment, the
identiﬁcation of co-occurring modiﬁcations within the same protein sequence, and the identiﬁcation of protein-binding
domains with afﬁnity towards modiﬁed peptides or nucleosomes [114,115]. However, it lacks the spatial resolution of
antibody-based ChIP approaches to map histone modiﬁcations to single genomic loci. To alleviate these shortcomings,
hybrid methods such as proteomics of isolated chromatin segments (PICh) or nascent chromatin capture (NCC) have
been developed to quantify proteins and histone modiﬁcations at abundant genomic regions [116] or newly replicated
DNA [117,118]. Moreover, the development of intracellular histone-modiﬁcation-speciﬁc binders [119] and reader
domain-based afﬁnity reagents [120] offer complementary strategies to traditional antibody-based and mass spectro-
metry strategies. The application of these methods will help us better understand how altered histone acetylation
pathways contribute to aging and aging-associated diseases, allowing the ﬁeld to establish how chromatin-modiﬁcation-
based epigenetic changes are coupled to other hallmarks of aging [1].show a strong polyacetylation bias and many H3 and H4 acetylation antibodies only weakly
discriminate among single individual acetylation events [37].
Antibody-independent approaches suggest that acetylation sites and the combinatorial patterns
they form with adjacent modiﬁcations bear more speciﬁc functions (Box 1). The binding of
bromodomains to acetylated lysines, for example, is strongly modulated by adjacent modiﬁ-
cations, including acetylation, methylation, and phosphorylation [38,39]. In line with these
ﬁndings, we recently suggested that the action of many acetyltransferases may be modulated
by ﬂanking modiﬁcations. This conclusion is based on measuring the abundance changes of
histone acetylation patterns by mass spectrometry after systematically depleting all known or
suspected acetyltransferases that are expressed in Drosophila melanogaster Kc cells [40,41].
Histone Acetylation Is Altered in Aging and Aging-Related Diseases
Altered histone acetylation patterns have been observed in aging tissues and are associated with
age-related maladies such as cancer, neurodegeneration, and others [4,42,43]. In many cases
the changes in histone acetylation are seen on bulk histones, suggesting that they are not
restricted to local and gene-speciﬁc changes in chromatin architecture but instead might
potentially induce large-scale alterations of chromatin.
The reduction of H4K16 acetylation and H4K20 methylation in cells derived from a primary
lymphoma has been shown to result in DNA hypomethylation of repetitive elements, which may
result in higher expression of these otherwise repressed genomic regions compared with normal
lymphocytes [44]. Reductions in various histone acetylation sites have also been implicated in
age-associated memory impairment in mice [43]. In this case, the downregulation of histone
acetylation on memory tasks such as fear conditioning in aged mice was shown to be linked to
age-associated transcription disruption [45,46]. Furthermore, increasing acetylation at H4K12
using histone deacetylase (HDAC) inhibitors (HDACis) improved memory in midlife mice [45],
although this observation was challenged in old rats [47]. Interestingly, higher levels of H4K12ac
were described to occur physiologically in other age-related phenomena, such as mice oocyteTrends in Biochemical Sciences, August 2016, Vol. 41, No. 8 703
infertility [48] and colon cancer [49], suggesting that the effects of age-associated alterations at
similar lysine acetylation sites might differ in different tissues.
Deregulation of cellular autophagy, one of the hallmarks of aging, was previously shown to be
associated with increased histone H3 acetylation in aging yeast [50]. In this model, restoration of
histone H3 acetylation levels enhanced the expression of autophagy-associated genes,
improved autophagy, and extended yeast lifespan [51]. Similarly, a previous study showed
that H4K16ac, a substrate of the deacetylase enzyme Sir2, increases during yeast replicative
aging [52]. Consistent with an increased level of acetylation during aging, speciﬁc acetylation
sites change in H3 and H4 when fruit ﬂies reach midlife [53]. We surmise that further mass
spectrometry-based measurements of histone modiﬁcations will increase our understanding of
combinatorial epigenetic deregulation in aging and age-associated maladies.
Age-Associated Metabolic Decline Is Coupled to Changes in Acetylation
Aging has been previously associated with a general decline of mitochondrial function [54–57]. In
line with this notion, a genetic mutation in the mitochondrial DNA polymerase was previously
shown to cause accelerated aging in mice [58]. Supporting the functional role of metabolic
decline during aging, mice with an accelerated aging phenotype show an altered serum
metabolome, including reduced citrate levels, an indicator for mitochondrial activity [59]. Oxygen
consumption rate is reduced in muscle ﬁbers isolated from elderly human patients, which
suggests that this tissue is also suffering decreased mitochondrial activity [60]. Nonetheless,
decreasing metabolic activity via caloric restriction or targeting the activity of key metabolic
regulators such as IGF-1, mTOR, and AMP kinase (AMPK) has often been associated with
extending lifespan [61]. A possible explanation for such opposing results is the recent ﬁnding that
transiently increased mitochondrial activity at earlier stages of aging (midlife) correlates with a
shorter lifespan [53,62]. Such an increase could explain why lowered caloric intake and hence
decreased metabolic activity at midlife can inhibit or delay age-associated metabolic increase.
The coupling of histone acetylation to general metabolism was previously shown to be mediated
via class III HDACs (sirtuins), which are dependent on the key metabolite NAD+ [63]. This is
underscored by the observation that caloric restriction-mediated increases in healthy lifespan
are partly achieved via overexpression of the Sir2 deacetylase [64]. Furthermore, the sirtuin
activator resveratrol was shown to have a beneﬁcial metabolic impact on obese humans by
promoting the activity of AMPK, SIRT1, and peroxisome proliferator-activated receptor gamma
coactivator 1-alpha (PGC-1/) [65]. It is worth noting that there have been controversial dis-
cussions about the exact role of sirtuins in the aging of S. cerevisae, C. elegans, and D.
melanogaster following rigorous control of the genetic background of the animals [66]. In
particular, a concern was raised that hybrid vigor may have contributed signiﬁcantly to the
observed difference in lifespan in C. elegans and D. melanogaster [66,67].
Nonetheless, recent studies have shown that overexpression of SIRT1 in the brain results in an
extended lifespan in mice [68]. Another study showed that whole-body SIRT6 overexpression
extends lifespan in mice [69]. In addition, new studies demonstrated that caloric restriction-
reduced mitochondrial protein acetylation was mediated by SIRT3 [70]. In line with these data,
lower NAD+ levels were measured in aged C. elegans, while restoration of the NAD+ level
resulted in an extended lifespan, which is dependent on FOXO-mediated transcription and the
presence of a functional Sir2 enzyme [29]. In mice, nuclear NAD+ levels improved the metabolic
health of old mice via increased transcriptional regulation in a SIRT1-dependent manner [71],
thereby further supporting a connection between sirtuin activity and aging. In summary, sirtuins
have been shown to counteract multiple established aging-related pathways such as oxidative
stress [72,73], protein folding stress [74–76], and genomic instability [77,78]. Considering the
transient increase in protein and histone acetylation during midlife [53], the beneﬁcial function of704 Trends in Biochemical Sciences, August 2016, Vol. 41, No. 8
sirtuins on lifespan extension might be due to sirtuin-mediated attenuation of this transient
hyperacetylation during the midlife of eukaryotic organisms.
Acetyl-CoA Metabolism Affects Histone Modiﬁcations during Aging
Metabolic activity is tightly linked with chromatin remodeling via histone acetylation [79]. KATs
utilize acetyl-CoA, a key metabolite primarily generated in mitochondria. Acetyl-CoA that is not
metabolized via the tricarboxylic acid (TCA) cycle can be transported from the mitochondria to
the cytosol by being converted to citrate; in the cytosol, citrate is cleaved back into oxaloacetate
and acetyl-CoA by ATP citrate lyase (ACLY/ATPCL) [80]. Besides ACLY/ATPCL, most eukar-
yotes also contain a cytosolic acetyl-CoA synthase (ACS), which can contribute to cytosolic
acetyl-CoA levels. However, the contribution of ACS to cytosolic acetyl-CoA levels is more
important in yeast than in higher eukaryotes [81]. As acetyl-CoA can freely diffuse into the
nucleus, depletion of ACLY/ATPCL in mammals results in lower histone acetylation levels [80],
thereby coupling metabolism directly to histone modiﬁcation [82–84]. In yeast, reduction of
cytosolic acetyl-CoA via reduction in the activity of acetyl-CoA synthase (ACS2p) results in
reduction of histone H3 acetylation, which is associated with increased autophagy and an
extended lifespan [51]. The same study demonstrated that reduction of acetyl-CoA synthase
resulted in an overall increased lifespan in Drosophila females. Consistent with these results, a
reduction of ATPCL activity, which is physiologically increased in midlife Drosophila males,
results in lower acetyl-CoA levels and lower acetylation of speciﬁc sites in histones H3 and H4
compared with wild-type ﬂies of the same age [53]. Supporting the notion that the increased
histone acetylation is related to the aging process, ﬂies with lower ATPCL activity show an
extended lifespan [53]. Similarly, another study demonstrated that age-related memory
impairment in Drosophila is linked with increased pyruvate carboxylase activity [85], thereby
linking acetyl-CoA levels to organismal aging.
The multiple connections between metabolic alterations and histone modiﬁcations suggest that
aging-related changes in metabolism and histone modiﬁcation are causally linked [51]. Muta-
tions in genes encoding histone-modifying enzymes have been shown to affect lifespan in
various model systems [4]. Several studies have demonstrated that very old animals and
senescent cells show generally lower histone acetylation [86,87]. In contrast to this observation,
old yeast cells show higher histone H4 acetylation levels than younger ones [52]. This apparent
contradiction might be reconciled by recent data that show increased histone acetylation when
animals reach midlife [51] mediated by transiently increased production of acetyl-CoA during
aging [53]. Consistent with the hypothesis that such a transient increase affects aging, loss-of-
function mutations of deacetylases results in shortened lifespan [88,89] whereas a mutation of
the gene encoding the H4K12ac-speciﬁc KAT Chameau results in lifespan extension in D.
melanogaster [53]. Mutations in other speciﬁc histone acetyltransferases, such as MOF [90], do
not increase lifespan, suggesting a very speciﬁc effect of this KAT on aging.
In age-associated maladies such as cancer, which are characterized not only by genetic factors
but also by metabolic alterations, oncogenic K-RAS causes a general increase in histone H3
and H4 acetylation via the activation of AKT1 and ACLY/ATPCL [91], which strongly supports
the link between the activity of metabolic enzymes and histone acetylation. The levels of
phosphorylated (active) AKT1 correlate very well with high levels of H3K9ac, H3K18ac, and
H4K12ac in human tumors, further supporting a direct connection between AKT1 activity and
metabolic activity. Interestingly, the activation of ACLY/ATPCL via AKT1 also connects meta-
bolic effects to signaling cascades previously associated with organismal aging [61,92] such as
IGF-1 signaling [93]. This intricate network of intracellular signaling pathways, central metabo-
lism, and chromatin packaging further illustrates the complexity of aging in eukaryotes and
explains why multiple pathways have been identiﬁed that can affect this process under
laboratory conditions [1].Trends in Biochemical Sciences, August 2016, Vol. 41, No. 8 705
Box 2. Multiple Connections between Metabolism and Epigenetic Processes Can Affect Transcription
and Longevity
In this review we focused on how acetyl-CoA metabolism impacts histone acetylation levels and transcription during
aging. However, other epigenetic modiﬁcations are also coupled to metabolic activity and could contribute to the
progress of aging and related disease. As histone and DNA methylation is also dependent on the availability of S-
adenosylmethionine (SAM), these modiﬁcations are also likely to be connected to metabolic processes. This is evident in
bees, for example, where early-life exposure to altered nutrition results in altered DNA methyltransferase Dnmt3 activity
and downstream DNA methylation changes that ultimately give rise to the long-lived queen bee [121]. Altered histone or
DNA methylation has been linked with various aging and longevity models [4].
Furthermore, it was recently shown that a mutation of the metabolic enzyme IDH results in the production of the
metabolite 2-hydroxyglutarate (2HG), a potent inhibitor of histone demethylases, which resulted in changes of repressive
histone methylations and an aberrant transcriptome in glioblastomas [122]. Thus, various metabolic signaling pathways
in aging may ultimately lead to chromatin and transcription changes.Although we chose to focus in our review on the connections of acetyl-CoA metabolism and
protein/histone acetylation, other links between metabolic processes and epigenetic phenom-
ena have also been established (Box 2). Thus, altered metabolic activity not only results in
changed levels of acetyl-CoA but will also have an effect on other metabolites that potentially
impact protein and histone post-translational modiﬁcations, thereby affecting lifespan or age-
related diseases [18,94].
We surmise that aging results in altered metabolic activity and thus changes in downstream
histone acetylation patterns as well as other epigenetic markers. Targeting the connectivity
between them appears to result in increased lifespan, highlighting potential therapeutic avenues
for age-related disease. It is likely that increases or decreases in the concentration of acetyl-CoA
will affect the activity of cell-type-speciﬁc KATs, since these enzymes in vitro display Km values in
the range of the cellular acetyl-CoA concentration [95]. Alterations in acetyl-CoA metabolism
could thus result in cell-type-speciﬁc age-associated transcriptome disruption [79] (Figure 2).
This may account for the different transcriptional response to aging processes observed in
various tissues and organisms [2]. Alternatively, but not mutually exclusively, acetylation changes
mediated by metabolic changes may result in noisy transcription, which would promote
progressive loss of homeostasis [53,79].
Therapeutic Application of HDACis
Targeting HDACs to restore the physiological function of many gene targets has attracted
signiﬁcant attention. Many studies have shown that administering HDACis could serve as a
therapeutic avenue in cancer, neurodegeneration, memory impairment, anti-inﬂammation, and
other conditions [42,96,97]. The rationale is that age-associated maladies are often character-
ized by lower histone acetylation (Figure 2, right panel) and thus inhibition of HDACs could
correct transcriptional misregulation via increasing histone acetylation levels. Maladies associ-
ated with large transcriptomic changes could thus be targeted by using inhibitors for speciﬁc
histone acetylation sites, potentially inducing changes in a large number of genes using a single
drug. HDACi and bromodomain-related therapies have become an attractive area of research
and several compounds are in clinical trials to treat cancer [42,98].
HDACi Therapy also Affects Non-Histone Targets
While histone acetylation has attracted considerable attention, other studies have shown that
non-histone proteins are also extensively acetylated [99,100]. Interestingly, acetyl-CoA-synthe-
sizing enzymes as well as many other enzymes involved in central metabolism were also shown
to be regulated via acetylation [101]. With advances in mass spectrometry-based techniques,
numerous studies have demonstrated that lysine acetylation is a widespread post-translational
modiﬁcation [70,102,103]. Interestingly, whereas the proportion of acetylated histone proteins is706 Trends in Biochemical Sciences, August 2016, Vol. 41, No. 8
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Figure 2. Metabolic Alterations in Aging Lead to Transcriptional Deregulation. Left: Young animals maintain a healthy connectivity between acetyl-CoA
metabolism, protein acetylation, and histone acetylation (indicated by yellow star) resulting in regulated transcriptomes and cellular homeostasis. Middle: As animals reach
midlife, small increases in metabolic activity increase the levels of acetyl-CoA and citrate. This shifts the balance towards higher levels of non-enzymatic as well as
enzymatic acetylation of proteins. We suggest that increased levels of nuclear acetyl-CoA, driven by increased ATP citrate lyase (ATPCL) activity, increase the enzymatic
activity of tissue-speciﬁc nuclear lysine acetyltransferases (KATs). This leads to an alteration of histone acetylation signatures and deregulation of gene expression. Such
deregulation may cause cellular damage, thus increasing metabolic stress, which in turn may result in even stronger deregulation. Right: In a similar manner, lower acetyl-
CoA metabolism may result in deregulated acetylomes, altered histone acetylation signatures, and a deregulated transcriptome. Such a general hypoacetylation of
chromatin has, however, not yet been demonstrated in living animals.high in cells (20–25% of histone H4 tails are acetylated in Drosophila and 40–50% in mice and
humans), for most non-histone proteins the degree of acetylation is unknown. Currently, to
detect many acetylated sites using a mass spectrometry approach, considerable pre-enrich-
ment of the acetylated proteins must be performed, making it difﬁcult to determine the exact
proportion of acetylated isoforms [102,104]. Presently, the relevance and role of the acetylation
of many non-histone proteins during aging remains unclear while we start to decipher the various
roles of such acetylation events (Box 3).
Previous studies suggested that acetylation of transcription factors could impact gene expres-
sion [99] and therefore might ‘rival’ histone acetylation in orchestrating gene expression. This is
an important aspect, since several studies have shown that HDACi treatment can impact gene
expression via increasing the acetylation of transcription factors; thus, such drugs should be
uniformly regarded as lysine deacetylase (KDAC) inhibitors (KDACis) [99]. We therefore need to
consider alternative mechanisms through which KDACis might act as therapeutic agents; for
example, by boosting metabolic activity [53] or through non-histone-dependent pathways. This
may be relevant in diseases linked to metabolic alterations. We expect new studies to show
revised conclusions on what is currently known about KDACi therapy [97,103] (Box 4). It is worth
mentioning that recent data suggest that some KAT/KDAC effects may occur not through
modulation of acetylation but rather by the modulation of acylation marks such as malonylation,
glutarylation, or succinylation [105,106]. It is thus important to monitor the concentrations of all of
these acyl-CoA substances. These acylations remain underexplored with regard to aging and
cancer but are likely to gain more importance.
Given that metabolic enzymes are partially regulated by acetylation and histone acetylation
regulates transcription, the overall cellular changes that are affected by KDACi treatment should
be revisited [94,103,107,108]. Such analyses, along with continuing improvements in advancedTrends in Biochemical Sciences, August 2016, Vol. 41, No. 8 707
Box 4. Revisiting the Mechanism of KDACis in Light of the Acetylome
The possible impact of KDACis on cellular metabolic activity has remained underexplored, despite their known effect on
the acetylation of metabolic enzymes [102,103,128]. Administration of the broad KDACi sodium butyrate or trichostatin A
to whole ﬂy-head tissue results in a transient and rapid increase of oxygen consumption, underscoring the effect of these
drugs on metabolism [53]. Considering the dependency of histone acetylation on acetyl-CoA levels [80], it is likely that
KDACis induce histone acetylation not only via direct inhibition of histone deacetylases but also because of their effects
on metabolism [53,109]. Furthermore, it is possible that KDACi-mediated epigenetic therapies exert their effects via
alternative and non-epigenetic pathways; for example, by affecting the acetylation of non-histone and non-chromatin
proteins. It is therefore possible that chronic administration of a KDACi could result in unwanted metabolic stress, with
substantial side effects [53]. Thus, it may be necessary to reinvestigate many KDACi-based treatments with regard to
their in vivo targets to enable better risk assessment and to potentially develop combination therapies that also target
metabolic pathways.
Outstanding Questions
What are the molecular mechanisms
that drive metabolic alterations during
early ageing? Are changes in post-
translational modiﬁcations of histones
and metabolic enzymes a cause or a
consequence of increased metabolic
activity?
Does caloric restriction and lower mito-
chondrial activity lead to an extension
of lifespan by counteracting increased
metabolic activity during midlife?
Can speciﬁc histone modiﬁcation pat-
terns be indicators of molecular ageing?
Does a general deterioration of tight
gene regulation lead to cellular aging
or are speciﬁc signaling pathways
involved in the aging process?
How much does non-histone acetyla-
tion contribute to the aging process?
What are the non-histone targets of
speciﬁc KDACis? Is the therapeutic
effect of KDACis in cancer, neurode-
generation, and other maladies due to
modulation of metabolism rather than
regulation of gene expression?
Are small-molecule modulators of met-
abolic enzymes potential drug candi-
dates to alleviate age-related disease?
Box 3. A Large Number of Non-Histone Proteins Are Acetylated
Recent developments in mass spectrometry technology have revealed thousands of non-histone acetylation sites
following enrichment of acetylated lysines using anti-acetyl-lysine antibodies [70,102,103]. Lysine acetylation has an
impact on multiple cellular pathways ranging from metabolism to gene expression [100]. Various metabolic enzymes
involved with acetyl-CoA metabolism are themselves acetylated, which results in the generation of multiple but often
hypothetical autoregulatory loops [101,123]. Interestingly, many acetylated proteins are detected in mitochondria, where
the evidence for speciﬁc lysine acetyltransferases is sparse. It has therefore been suggested that a large fraction of
mitochondrial acetylation might be the result of non-enzymatic acetylation [124]. Consistent with the observation that
most of the known acetyltransferases are found in the nucleus, a substantial fraction of acetylated proteins are also found
in the nucleus, where acetylation regulates chromatin packaging and transcription [99,107]. Besides its effect on
metabolic regulation and gene expression, protein acetylation has also been implicated in the regulation of DNA repair
[108], autophagy [125], and protein stability [126,127].
Intracellular acetyl-CoA levels are known to change dynamically in response to multiple physiological stimuli or
pathological processes [94]. It is therefore likely that future studies will link speciﬁc protein acetylations to the progression
of speciﬁc diseases, thereby unraveling novel drug targets for protein acetylation.mass spectrometry-based and computational tools to precisely measure post-translational
modiﬁcations of histones and non-histone proteins, will lead to an improved characterization
of metabolic–epigenetic deregulation in aging and disease. This should lead to the development
of more speciﬁc drugs while limiting their side effects.
Concluding Remarks
There is growing evidence that chromatin remodeling via histone acetylation is tightly linked to
metabolic activity [5,109]. It is evident that age-associated alterations in metabolic activity
change the concentration of acetyl-CoA and of citrate and therefore will affect cytosolic levels
of acetyl-CoA. Changes in this metabolite will immediately affect other metabolic processes such
as the synthesis of fatty acids, which may have an effect on multiple aspects of cellular
physiology. However, changes in acetyl-CoA can also impact levels of histone acetylation
and disrupt the regulation of transcription as animals age or develop aging-related diseases
[51,53]. It is likely that distinct KAT and KDAC enzymes possess speciﬁc afﬁnities for their
cofactors acetyl-CoA and NAD+, respectively, and may thus respond differently to age-associ-
ated alterations in cofactor concentrations [2]. Moreover, additional connections between
metabolic activity and other epigenetics marks (methylation, phosphorylation, butyrylation,
and others) may also contribute to age-associated transcriptional regulation. We expect that
further experiments uncovering even closer connections between metabolic changes in aging
and the deregulation of gene expression will offer new strategies to increase healthy lifespan and
prevent related diseases [61].
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